The North America Bupivacaine Liposome Injectable Suspension landscape is experiencing notable expansion, supported by rising surgical volumes and the growing emphasis on effective postoperative pain management. Healthcare systems across the United States and Canada are increasingly prioritizing patient recovery, reduced hospital stays, and minimized opioid use. This has accelerated the...